JP2022534846A5 - - Google Patents
Info
- Publication number
- JP2022534846A5 JP2022534846A5 JP2021561906A JP2021561906A JP2022534846A5 JP 2022534846 A5 JP2022534846 A5 JP 2022534846A5 JP 2021561906 A JP2021561906 A JP 2021561906A JP 2021561906 A JP2021561906 A JP 2021561906A JP 2022534846 A5 JP2022534846 A5 JP 2022534846A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025070050A JP2025118689A (ja) | 2019-05-29 | 2025-04-22 | 多量体ｔ細胞調節性ポリペプチド及びその使用方法 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962854200P | 2019-05-29 | 2019-05-29 | |
| US62/854,200 | 2019-05-29 | ||
| US201962872048P | 2019-07-09 | 2019-07-09 | |
| US62/872,048 | 2019-07-09 | ||
| US201962901538P | 2019-09-17 | 2019-09-17 | |
| US62/901,538 | 2019-09-17 | ||
| PCT/US2020/034939 WO2020243315A1 (en) | 2019-05-29 | 2020-05-28 | Multimeric t-cell modulatory polypeptides and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025070050A Division JP2025118689A (ja) | 2019-05-29 | 2025-04-22 | 多量体ｔ細胞調節性ポリペプチド及びその使用方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022534846A JP2022534846A (ja) | 2022-08-04 |
| JPWO2020243315A5 JPWO2020243315A5 (https=) | 2023-05-23 |
| JP2022534846A5 true JP2022534846A5 (https=) | 2023-05-23 |
| JP7762068B2 JP7762068B2 (ja) | 2025-10-29 |
Family
ID=73552689
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021561906A Active JP7762068B2 (ja) | 2019-05-29 | 2020-05-28 | 多量体ｔ細胞調節性ポリペプチド及びその使用方法 |
| JP2025070050A Withdrawn JP2025118689A (ja) | 2019-05-29 | 2025-04-22 | 多量体ｔ細胞調節性ポリペプチド及びその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025070050A Withdrawn JP2025118689A (ja) | 2019-05-29 | 2025-04-22 | 多量体ｔ細胞調節性ポリペプチド及びその使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220017596A1 (https=) |
| EP (1) | EP3976084A4 (https=) |
| JP (2) | JP7762068B2 (https=) |
| KR (1) | KR20220015382A (https=) |
| CN (2) | CN118852456A (https=) |
| AU (1) | AU2020282736B2 (https=) |
| CA (1) | CA3137463A1 (https=) |
| IL (1) | IL287192A (https=) |
| MX (1) | MX2021014476A (https=) |
| WO (1) | WO2020243315A1 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3019005A1 (en) * | 2016-05-18 | 2017-11-23 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| CN116970059A (zh) | 2016-12-22 | 2023-10-31 | 库尔生物制药有限公司 | T细胞调节性多聚体多肽及其使用方法 |
| US11851471B2 (en) | 2017-01-09 | 2023-12-26 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| IL269000B2 (en) | 2017-03-15 | 2024-06-01 | Cue Biopharma Inc | Methods for modulating an immune response |
| TW201920249A (zh) | 2017-09-07 | 2019-06-01 | 美商信號生物製藥公司 | 具有結合位點之t細胞調節多聚體多肽及其使用方法 |
| WO2019139896A1 (en) | 2018-01-09 | 2019-07-18 | Cue Biopharma, Inc. | Multimeric t-cell modulatory polypeptides and methods of use thereof |
| AU2019401183A1 (en) * | 2018-12-19 | 2021-08-12 | Cue Biopharma, Inc. | Multimeric T-cell modulatory polypeptides and methods of use thereof |
| WO2020168122A1 (en) | 2019-02-13 | 2020-08-20 | Beam Therapeutics Inc. | Modified immune cells having adenosine deaminase base editors for modifying a nucleobase in a target sequence |
| EP4034138A4 (en) | 2019-09-27 | 2024-07-31 | Beam Therapeutics, Inc. | COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIQUID CANCERS |
| EP4048402A4 (en) * | 2019-10-23 | 2023-11-22 | Cue Biopharma, Inc. | MODIFIED CYTOTOXIC T CELLS AND METHOD OF USE THEREOF |
| TW202208395A (zh) | 2020-05-12 | 2022-03-01 | 美商信號生物製藥公司 | 多聚體ｔ細胞調節多肽及其使用方法 |
| EP4211149A4 (en) | 2020-09-09 | 2024-10-09 | Cue Biopharma, Inc. | MULTIMERIC POLYPEPTIDES MODULATING MHC CLASS II T CELLS FOR THE TREATMENT OF TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF |
| EP4304725A1 (en) | 2021-03-09 | 2024-01-17 | CDR-Life AG | Rabbit-derived antigen binding protein nucleic acid libraries |
| JP2024512470A (ja) * | 2021-03-19 | 2024-03-19 | キュー バイオファーマ， インコーポレイテッド | Ｔ細胞調節ポリペプチド及びその使用方法 |
| CA3224341A1 (en) | 2021-09-01 | 2023-03-09 | Novartis Ag | Pharmaceutical combinations comprising a tead inhibitor and uses thereof for the treatment of cancers |
| EP4436600A4 (en) * | 2021-11-24 | 2025-10-01 | Cue Biopharma Inc | MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF |
| KR20240116828A (ko) * | 2021-12-14 | 2024-07-30 | 씨디알-라이프 아게 | 이중 mhc-표적화 t 세포 관여자 |
| JP2025515575A (ja) * | 2022-04-14 | 2025-05-20 | キュー バイオファーマ， インコーポレイテッド | Ｔ細胞エンゲージングポリペプチドおよびその使用方法 |
| CN115838432B (zh) * | 2022-07-08 | 2023-12-08 | 浙江大学 | 一种靶向调控抗原特异性t细胞的融合蛋白及应用 |
| CN116063463B (zh) * | 2022-08-12 | 2025-08-01 | 辽宁成大生物股份有限公司 | 抗rHPV68 L1蛋白CD68单克隆抗体、rHPV68型蛋白抗原的检测试剂盒 |
| WO2024044750A2 (en) * | 2022-08-26 | 2024-02-29 | Beam Therapeutics Inc. | Modified allogeneic cells and methods and compositions for the preparation thereof |
| KR20250067130A (ko) | 2022-09-14 | 2025-05-14 | 씨디알-라이프 아게 | Mage-a4 펩티드 이중 t 세포 연결체 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1454138E (pt) * | 2001-12-04 | 2012-03-28 | Merck Patent Gmbh | Imunocitoquinas com seletividade modulada |
| US7977457B2 (en) * | 2006-05-19 | 2011-07-12 | Teva Pharmaceutical Industries Ltd. | Fusion proteins, uses thereof and processes for producing same |
| CN102958942A (zh) * | 2009-12-29 | 2013-03-06 | 新兴产品开发西雅图有限公司 | 异二聚体结合蛋白及其应用 |
| CN104768571B (zh) * | 2012-07-13 | 2018-11-09 | 酵活有限公司 | 多价异多聚体支架设计和构建体 |
| CA2889788A1 (en) * | 2012-12-21 | 2014-06-26 | F. Hoffmann-La Roche Ag | Disulfide-linked multivalent mhc class i comprising multi-function proteins |
| CA2902739C (en) * | 2013-03-15 | 2022-11-22 | Xencor, Inc. | Heterodimeric proteins |
| PL3157552T3 (pl) * | 2014-06-18 | 2020-05-18 | Albert Einstein College Of Medicine | Polipeptydy syntac i ich zastosowania |
| CA3014458A1 (en) * | 2016-03-02 | 2017-09-08 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| AU2017225787B2 (en) * | 2016-03-03 | 2021-09-23 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| KR102687530B1 (ko) * | 2016-05-04 | 2024-07-25 | 암젠 인크 | T-조절 세포의 증식을 위한 인터류킨-2 뮤테인 |
| CA3019005A1 (en) * | 2016-05-18 | 2017-11-23 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| CN116970059A (zh) * | 2016-12-22 | 2023-10-31 | 库尔生物制药有限公司 | T细胞调节性多聚体多肽及其使用方法 |
| US11851471B2 (en) * | 2017-01-09 | 2023-12-26 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| IL269000B2 (en) * | 2017-03-15 | 2024-06-01 | Cue Biopharma Inc | Methods for modulating an immune response |
| WO2018187190A1 (en) * | 2017-04-06 | 2018-10-11 | Albert Einstein College Of Medicine, Inc. | Precision activation of hiv-specific ctls to eliminate reactived latent t cells |
| TW201920249A (zh) * | 2017-09-07 | 2019-06-01 | 美商信號生物製藥公司 | 具有結合位點之t細胞調節多聚體多肽及其使用方法 |
| WO2022119958A1 (en) * | 2020-12-02 | 2022-06-09 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
-
2020
- 2020-05-28 CN CN202410806389.2A patent/CN118852456A/zh active Pending
- 2020-05-28 KR KR1020217037009A patent/KR20220015382A/ko active Pending
- 2020-05-28 WO PCT/US2020/034939 patent/WO2020243315A1/en not_active Ceased
- 2020-05-28 JP JP2021561906A patent/JP7762068B2/ja active Active
- 2020-05-28 AU AU2020282736A patent/AU2020282736B2/en active Active
- 2020-05-28 CN CN202080035915.XA patent/CN114126635A/zh active Pending
- 2020-05-28 MX MX2021014476A patent/MX2021014476A/es unknown
- 2020-05-28 CA CA3137463A patent/CA3137463A1/en active Pending
- 2020-05-28 EP EP20815621.6A patent/EP3976084A4/en active Pending
-
2021
- 2021-09-30 US US17/490,516 patent/US20220017596A1/en active Pending
- 2021-10-12 IL IL287192A patent/IL287192A/en unknown
-
2025
- 2025-04-22 JP JP2025070050A patent/JP2025118689A/ja not_active Withdrawn